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ABSTRACT
The ProteomeXchange (PX) consortium of proteomics resources (http://www.proteomexchange.
org) has standardized data submission and dissemination of mass spectrometry proteomics data worldwide since 2012. In this paper, we describe the main
developments since the previous update manuscript
was published in Nucleic Acids Research in 2017.
Since then, in addition to the four PX existing members at the time (PRIDE, PeptideAtlas including the
PASSEL resource, MassIVE and jPOST), two new resources have joined PX: iProX (China) and Panorama
Public (USA). We first describe the updated submission guidelines, now expanded to include six members. Next, with current data submission statistics,
we demonstrate that the proteomics field is now actively embracing public open data policies. At the
end of June 2019, more than 14 100 datasets had
been submitted to PX resources since 2012, and from
those, more than 9 500 in just the last three years.
* To
†

In parallel, an unprecedented increase of data re-use
activities in the field, including ‘big data’ approaches,
is enabling novel research and new data resources.
At last, we also outline some of our future plans for
the coming years.
INTRODUCTION
Mass spectrometry (MS)-based proteomics approaches are
becoming increasingly prominent in the life sciences. Since
its inception, the ProteomeXchange (PX) consortium of
proteomics resources (1,2) (http://www.proteomexchange.
org) has aimed to standardize data submission and dissemination of public MS proteomics data worldwide. The implementation of the PX consortium formally started in 2012
and since then, it has become the de facto standard for sharing MS proteomics datasets in the public domain. Thanks
to the perceived reliability of PX resources and in parallel, to the requirements of scientific journals and funding
agencies, common practice has changed rapidly in the proteomics field and data sharing has become the norm.
The first stable implementation of the PX data workflow (1) started in 2012 and involved two resources at the
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time: the PRIDE database (3) (European Bioinformatics
Institute, EMBL-EBI, Hinxton, UK) and the PASSEL (4)
resource within PeptideAtlas (Institute for Systems Biology, Seattle, WA, USA), a specialized repository for SRM
(Selected Reaction Monitoring) experiments. Additionally,
PeptideAtlas (5) participated as a resource that re-analyzed
public submitted datasets. Two additional resources, MassIVE (University of California San Diego, CA, USA) and
jPOST (6) (the jPOST project, Japan) joined in 2014 and
2016, respectively, demonstrating the global reach of PX.
A common data access portal called ProteomeCentral was
also developed (http://proteomecentral.proteomexchange.
org), providing the ability to search for datasets in all participating PX resources at once. The submitted dataset files
remain in the receiving resources but are then linked from
ProteomeCentral. PX resources support and implement the
relevant MS related open data formats of the Proteomics
Standards Initiative (PSI) (7,8) and develop and maintain
open-source software, including several parser libraries and
tools to support these data standards (9,10).
All PX resources share the same dataset identifier
space (PXD or RPXD identifiers, see http://www.ebi.ac.
uk/miriam/main/collections/MIR:00000513). Additionally,
resources may also use their own custom identifiers for
non-proteomics MS datasets or datasets that do not fully
comply with PX guidelines (e.g. MassIVE also supports
metabolomics datasets submitted through GNPS (11)), but
these are not tracked and announced via PX.
Here we provide an update of the activities of the PX consortium and its individual resources since the previous update paper was published in Nucleic Acids Research (NAR)
three years ago (2), including a description of the updated
submission guidelines, which now reflect PX’s further expansion to six members. We will also highlight different submission statistics to demonstrate the wide adoption of PX,
highlight data re-use activities and discuss future developments.
EXPANSION OF THE CONSORTIUM AND UPDATED
SUBMISSION GUIDELINES
All PX receiving resources store MS proteomics data in
a place independent from the control of the original data
generators, providing private access for reviewers and journal editors during the manuscript review process. See Table
1 for accessing the basic information about each resource.
Table 2 provides a summary of the main functionality offered by the PX members. More detailed information is
available in Supplementary File 1. The updated submission
guidelines, including now all six members, are available at
http://www.proteomexchange.org/docs/guidelines px.pdf.
Two additional resources have joined the consortium in
the last three years: iProX (12) (National Center for Protein Sciences, Beijing, China) in 2017, and Panorama Public
(13) (University of Washington, Seattle, WA, USA) in 2018.
iProX is a universal data resource (see Section 1 in the submission guidelines for additional details), which can store
any type of proteomics datasets, primarily supporting Chinese proteomics researchers. On the other hand, Panorama
Public is a focused resource, tailored for targeted proteomics
approaches.

There are two main data submission workflows, called
‘Complete’ and ‘Partial’. For both submission types, it is
mandatory to include a set of common experimental metadata at the level of each dataset (encoded in the shared PX
XML format, which is used by ProteomeCentral), raw mass
spectra and the submitter’s processed results (identification
and/or quantification data) are always mandatory in each
submitted dataset. In the case of a ‘Complete’ dataset, it is
additionally required that the receiving PX resource is able
to parse, process and directly connect all individual results
with the submitted raw data. This can be achieved if the processed results and the corresponding raw data are available
in supported standard data formats like those developed by
the PSI (e.g. mzIdentML (14) and mzTab (15)) or in open
formats related to Skyline, in the case of Panorama Public.
In contrast, ‘Partial’ datasets contain result files that are
not in open standard formats that can be parsed and thus ingested by the receiving repository. The metadata still make
the datasets findable in the receiving repository and in ProteomeCentral. In these cases, datasets may then be downloaded and interpreted if suitable software to parse or visualize the files is available. Or the data may be reprocessed
using the mandatory raw data as the base. In fact, using the
‘Partial’ dataset submission mechanism, virtually any type
of proteomics data workflow is supported.
An overview of the current PX resources and data workflows is shown in Figure 1. PRIDE, MassIVE, jPOST and
iProX are considered to be universal archival resources.
At present all of them store datasets mainly coming from
DDA (Data Dependent Acquisition) workflows, but they
can support other data workflows as well, for instance DIA
(Data Independent Acquisition) and top down proteomics,
among others, mainly as ‘Partial’ datasets (see submission
guidelines for additional details).
PASSEL and Panorama Public, the remaining PX resources, are so-called focused resources aimed at targeted
proteomics approaches. PASSEL supports any type of
SRM data workflows whereas Panorama Public supports
results from all quantitative, targeted proteomics workflows
enabled by the popular Skyline software ecosystem (16).
The other PX members do not actively solicit submission
of targeted proteomics data and instead recommend submission to the appropriate focused resources (PASSEL and
Panorama Public).

REPRESENTATION OF REPROCESSED DATASETS
AND INTEGRATION WITH OTHER PUBLIC OMICS
DATASETS
In addition to original submitted datasets, PX supports
the storage and dissemination of re-analyzed versions of
datasets that were originally submitted to one of the PX resources. If they are re-analyzed by the PX resources using
their own analysis pipelines, these datasets get an identifier
of the format RPXD and are also made available through
ProteomeCentral, like it happens in the case of PeptideAtlas
and MassIVE re-analyzed datasets at present. In all RPXD
datasets, the original source of the data is always properly
cited and acknowledged with direct links to the original
datasets.
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Table 1. Overview of the main characteristics of the current PX resources
Resource Name
PRIDE

Institution, Country
European Bioinformatics
Institute (EMBL-EBI),
Cambridge, UK
Institute for Systems
Biology, Seattle, WA, USA
Institute for Systems
Biology, Seattle, WA, USA
University of California,
San Diego, CA, USA

URL
http://www.ebi.ac.uk/pride

Function in PX
Archival
(Universal)

Contact
pride-support@ebi.ac.uk

http://www.peptideatlas.org/

Re-analysis

http:
//www.peptideatlas.org/passel/
https://massive.ucsd.edu/

Archival (Focused)

http:
//www.peptideatlas.org/feedback.php
http:
//www.peptideatlas.org/feedback.php
ccms-web@cs.ucsd.edu

jPOST

The jPOST project, Japan

https://jpostdb.org/

iProX

National Center for
Protein Sciences, Beijing,
China
University of Washington,
Seattle, WA, USA

https://www.iprox.org/

PeptideAtlas
PASSEL
MassIVE

Panorama Public

https:
//panoramaweb.org/public.url

Archival
(Universal),
Re-analysis
Archival
(Universal)
Archival
(Universal)

https://repository.jpostdb.org/contact
iprox@iprox.org

Archival (Focused)

panorama@proteinms.net

Table 2. Main functionality offered by the PX resources
Data types/ submission types
Types of data access
Web interface
Application Programming Interface
Protocol for file transfer (download/
upload)
Reviewer private access
General functionality/web
visualization
Dataset centric view
Protein centric view across resource
Annotated mass spectra
Chromatograms
Support for RPXD datasets
Standalone tools for re-using datasets
Data Visualisation
Data Analysis
Online data analysis pipelines

PRIDE

PASSEL

MassIVE

jPOST

iProX

Panorama
Public

Peptide Atlas

Yes
Yes (42)
FTP, Aspera

Yes
Yes
FTP

Yes
Yes
FTP

Yes

Yes
Yes
HTPP, Aspera

Yes
Yes
WebDAV

Yes
Yes
FTP

File download

File download

File download,
web interface

File download

File download,
web interface

File download,
web interface

N/A

Yes

Yes
Yes
Yes
Yes

Yes
Yes (23)
Yes

Yes

Yes

Yes

Yes

Yes

Yes
Yes

Yes
Yes
Yes

Yes

FTP

Yes
PRIDE Inspector
(10)
PeptideShaker (43)

Yes
Skyline (16)
Skyline

23 different
workflows

Figure 1. Overview figure including the current ProteomeXchange data workflow and additional bioinformatics resources that are currently re-using
proteomics data.
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As of September 2019, a framework to formalize
the representation of different versions of reprocessed
datasets by the same PX resource has just been finalized. The corresponding guidelines for reprocessed
datasets are available at http://www.proteomexchange.org/
docs/reprocessed guidelines px.pdf. This functionality is
now available via 230 re-analysis containers (see e.g.
RPXD000669), altogether aggregating 460 re-analyses
(e.g. using different algorithms or processing complementary subsets of the data), each of which is associated with an
identifier such as RPXD000669.x that combines the RPXD
for the container with a number suffix (denoted here as ‘x’)
indicating a single re-analysis of the primary data. See all
the details in the guidelines for reprocessed datasets.
In our view, appropriate integration of proteomics
datasets with other types of public ‘omics datasets is of
paramount importance. In this context, datasets in PX resources are included in the OmicsDI (Omics Discovery
Index) portal (http://www.omicsdi.org). The objective of
OmicsDI is to provide a centralized access point to omics
datasets coming from different omics approaches including
genomics, transcriptomics, proteomics and metabolomics,
linking where possible, multi-omics datasets coming from
the same study but available in different resources (17). Recently, OmicsDI has implemented a system to assess the scientific ‘impact’ of omics datasets (18). As a key point, scientists can create their own profiles in OmicsDI, listing their
datasets (for instance PX datasets) including several indicators of their scientific impact.
KEY DEVELOPMENTS IN THE INDIVIDUAL PX RESOURCES
Next, we will highlight some of the recent key developments
in the different resources. First of all, PRIDE has been completely redeveloped and a new web and programmatic interfaces are now available. On one hand, this completely new
infrastructure supports the increase in the number and volume of submitted datasets and on the other, new features
and visualization capabilities. In parallel, PRIDE is increasingly integrating proteomics data in other EMBL-EBI resources (3) such as UniProt (19) (phosphorylation information), Ensembl (20) (proteogenomics) and Expression Atlas
(21) (quantitative proteomics experiments).
As explained in Section 3, MassIVE has developed a
comprehensive infrastructure for the systematic re-analysis
of public datasets, as well as major new developments
to aggregate re-analyses into re-usable community knowledge and a new interface for interactive exploration of
repository-scale peptide and protein data. First, MassIVE
developed new infrastructure for systematic re-analysis of
public datasets and applied it to over 30 TBs of human data
to derive 364 million new identifications at controlled false
discovery rates, all of which are easily accessible at a new
simple MassIVE search interface. Second, MassIVE also
implemented the concept of publicly accessible re-analyses
that are attached to MassIVE datasets (and thus visible
whenever the dataset is accessed), as well as the concept
of re-analysis containers used to group sets of related reanalyses, as mentioned in the previous section. Third, MassIVE capitalized on these large-scale re-analyses to build

the largest human spectral library to date (the MassIVEKB knowledge base (22)), with spectra from over 2 million
unique precursor ions covering over 6 million aminoacids
from >19 000 canonical human proteins. At last, MassIVE also developed the new Protein Explorer interface
(23) to deliver intuitive protein-centric access to hundreds
of millions of identifications across datasets, while also
cross-referencing MS identifications with functional information from external resources (e.g. UniProt and PhosphoSitePlus).
The jPOST project team has launched a new data journal,
Journal of Proteome Data and Methods (JPDM, http://www.
jhupo.org/jpdm/), to collect precise and detailed metadata.
JPDM focuses in both data and metadata and is closely related to jPOST. For example, when users submit their data
to the jPOST repository with the minimum required metadata, jPOST provides a template for manuscript submission to JPDM. On one hand, submitters have incentives to
improve the FAIRness (Findable, Accessible, Interoperable
and Re-useable (24)) of their datasets and publish an additional paper. On the other hand, the repository has the advantage of the additional collected detailed metadata. Once
the paper is accepted in JPDM, the metadata will feedback to jPOST. Although this framework was started by
the jPOST team, submissions to JPDM are welcome, also
where the corresponding datasets are submitted to other PX
resources.
DATA RE-USE ACTIVITIES IN THE FIELD
As a consequence of the unprecedented availability of proteomics data in the public domain, data re-use continues to increase (e.g. (25,26)). Some of the most popular
approaches involve the creation of the spectral libraries
(22,27), re-analyses activities in the context of the Human Proteome Project ((28), (23) and others), following
well-established guidelines (29), and proteogenomics studies, among others. Additionally, it is important to highlight
in this context that PX resources are supporting emerging ‘big data’ approaches involving proteomics data, such
as machine/deep learning studies. The first studies of this
kind are starting to appear in the literature, devoted to e.g.
MS/MS spectrum prediction (30–32).
Furthermore, as a key point, external bioinformatics resources to PX are increasingly re-using and integrating proteomics data with other biological data types. Figure 1 highlights some of those resources, including: (i) Protein knowledge bases (UniProt (19) and neXtProt (33)), to support
information about each protein’s experimental evidence;
(ii) Genome browsers (Ensembl (20) and UCSC Genome
Browser (34)), where it is possible to integrate proteomics
and genomics information using ‘TrackHubs’ (35); (iii) Proteomics resources which re-analyze PX datasets, such as
GPMDB (36) and proteomicsDB (37); (iv) EMBL-EBI’s
Expression Atlas (21), a resource where protein expression
information is increasingly made available together with
gene expression data; (v) proteogenomics resources such as
LNCipedia (38) and sORF.org (39), where public datasets
are routinely reanalyzed to search for evidence of translation for long-non-coding RNAs and short Open Reading
Frames, respectively; and (vi) other specialized resources
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such as SysteMHC Atlas (40) (for immunopeptidomics
data) and OpenProt (41). We anticipate that the number of
resources re-using public proteomics data will only increase
in the near future.
OVERALL DATA SUBMISSION AND DATA ACCESS
STATISTICS
By the end of June 2019, a total of 14 169 datasets had
been submitted to PX resources. Of those, 8 638 datasets
(61.0%) were already publicly available, whereas the rest
were still unreleased (5 531 datasets, 39.0%). Since 2012,
the number of submitted datasets has increased substantially every year, a trend that has not stopped yet (Figure 2). If we consider just the last couple of years, during 2017 and 2018, 2 711 and 3 632 datasets were submitted to PX resources, respectively. During the first 6 months
of 2019, the number is already 2 224 datasets. In terms of
distribution of datasets across individual resources, 12 335
datasets (87.1%), had been submitted to PRIDE, followed
by MassIVE (1 126 datasets, 7.9%), jPOST (352 datasets,
2.5%), iProX (174 datasets, 1.2%), PASSEL (139 datasets,
1.0%) and Panorama Public (43 datasets, 0.3%). Datasets
come from 50 different countries, demonstrating the global
reach of PX. The five most represented countries (Figure
3) are USA (2 937 datasets, 20.7%), China (2 100 datasets,
14.8%), Germany (1 947 datasets, 13.7%), United Kingdom (1 125 datasets, 7.9%) and France (621 datasets, 4.3%).
The top five species represented (Figure 3) are: Homo sapiens (6 802 datasets, 48.0%), Mus musculus (2 139 datasets,
15.0%), Arabidopsis thaliana (500 datasets, 3.5%), Saccharomyces cerevisiae (496 datasets, 3.5%), and Escherichia coli
(470 datasets, 3.3%).
PXD accession numbers are now widely used in journal
articles to cite datasets. As of August 2019, the number of
publications referring to PX datasets in Europe PubMed
Central was 5 064, which included the number of occurrences in the abstract for all articles and in the full text for
those articles that are open access.
Sustainability of accessible public repositories is a key
factor. To ensure long-term data availability, the PX members have committed to importing the data available in any
of the other PX resources if the resource has funding problems and must cease its operations. As an additional incentive towards sustainability, data are also routinely replicated across resources to enable systematic re-analyses, as
MassIVE currently illustrates with more than 500 datasets
already imported from other PX resources (mainly from
PRIDE). The combined file size of all PX resources (as of
30 June 2019, including mirrored datasets) was ∼1.3 PBs.
LICENSING OF DATASETS
So far, licenses for datasets stored in PX resources have not
been uniform. However, all PX resources have decided to
move towards a default Creative Commons CC0 license as
a minimum level in the coming months, making available
globally datasets without any restrictions. It is important to
highlight that CC0 was already the default existing license
for datasets in MassIVE and jPOST. Additionally, PRIDE
follows the EMBL-EBI ‘Terms of use’ (https://www.ebi.ac.

uk/about/terms-of-use) and iProX has their own data license terms (https://www.iprox.org/page/iproxDataLisence.
html). PeptideAtlas/PASSEL and Panorama Public did not
have formalized licenses so far.
It should be noted that, once fully formalized, CC0 license can only be ensured for prospective newly submitted
datasets, at least for those PX resources that were not enforcing CC0 already. In the near future, all members aim to
move to a default CC-BY. In fact, as of September 2019 CCBY 4.0 is already the default license applied to new datasets
submitted to Panorama Public. CC-BY, in addition to the
characteristics of the CC0 license, requires attribution to
the original data generators/data submitters. The reason
for the rest of the partners to not moving directly into CCBY is that, at present, the legal consequences of using CCBY for some ‘downstream’ data re-uses are not fully understood. One example that illustrates this is whether a scientist re-using a spectral library produced by one of the PX
resources, would be required to give attribution to all original data generators whose datasets where used to build the
library.
Independently from this, we want to stress that attribution should always be provided to the original data generators, as it is already happening routinely in the field (i.e. the
original publication and/or dataset identifier should be always cited when re-using PX datasets).
DISCUSSION AND FUTURE PLANS
PX continues to support the open data culture in the field by
promoting and enabling the sharing of proteomics data in
the public domain. An increasing number of scientific journals mandate submission of the generated datasets accompanying the submitted manuscripts, including the main proteomics journals (Molecular and Cellular Proteomics, Journal of Proteome Research, Proteomics) and journals from
the Nature and PLOS groups, among others. We are happy
to work with other journals to support increasingly-strict
guidelines for data deposition.
PX resources are committed to comply with the FAIR
principles (24) for biological data. We will then follow
closely developments in this area, like those led by ELIXIR
(https://elixir-europe.org/) in Europe. In this context, a key
aspect that we aim to improve in the near future is the annotation of the datasets. The current requirements were set up
in 2011 (with minor updates in 2013), reflecting the discussions at the time, involving many key stakeholders in the
field. In order to increase re-usability of datasets, we are
working towards enabling improvements in metadata annotation by the data submitters, but also a posteriori by data
curators and other third parties.
We are also currently actively working on the development of a common Application Programming Interface
(API) called ProXI to access mass spectra, peptide spectrum matches, peptides, proteins and dataset metadata in
a uniform fashion in all PX resources. Additionally, access to mass spectra will be enabled by using the Universal
Spectrum Identifier (USI, http://www.psidev.info/usi) system, still under development.
One increasingly relevant topic is the management of
clinical, potentially sensitive, proteomics data and whether
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Figure 2. Number of submitted datasets per month to PX resources, ranging from May 2012 to June 2019.

Figure 3. Summary of metrics for datasets available in all ProteomeXchange resources (as of 30 June 2019).
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they should be considered as patient identifiable or not. This
topic has recently gained more relevance after the introduction of the GDPR (General Data Protection Regulation)
guidelines by the European Union. The proteomics community needs to develop rules and best-practice guidelines for
dealing with this type of datasets and, moreover, to evaluate
the alignment of these efforts with the genomics and transcriptomics communities. We anticipate that it is likely that
some proteomics datasets will need to be controlled-access,
so alternative data submission mechanisms will have to be
developed for those. At present, authors that have already
been advised to follow different data management practices
for potentially sensitive proteomics datasets, are advised
to contact resources such as EGA (European Genotypephenome Archive), dbGAP or JGA (Japanese Genotypephenotype Archive).
It is important to note that the consortium remains
open to accept new members. At last, we want to highlight that up to date documentation is linked from the
PX website (http://www.proteomexchange.org/). For regular announcements of all the new publicly available
datasets, users can follow our Twitter account (@proteomexchange) or subscribe to the following Rich Site Summary (RSS) feed (https://groups.google.com/forum/feed/
proteomexchange/msgs/rss v2 0.xml).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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